Expression of FKBP12 in benign and malignant vascular endothelium: An immunohistochemical study on conventional sections and tissue microarrays

American Journal of Surgical Pathology

Volumn 27, Issue 1, 2003, Pages 58-64

  Higgins, John P T ^a   Montgomery, Kelli ^a   Wang, Lingli ^a   Domanay, Elizabeth ^a   Warnke, Roger A ^a   Brooks, James D ^a   Van de Rijn, Matt ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

FK506; Immunohistochemistry; Tissue microarray; Vascular; Westem blot

Indexed keywords

CALCINEURIN; CD31 ANTIGEN; CD34 ANTIGEN; IMMUNOPHILIN; PROTEIN FKBP12; TACROLIMUS; UNCLASSIFIED DRUG;

ANGIOSARCOMA; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; DRUG EFFECT; EPIDERMIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SENSITIVITY AND SPECIFICITY; THYMUS; TISSUE SECTION; TUMOR DIFFERENTIATION; VASCULAR ENDOTHELIUM; VASCULAR TUMOR; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; ENDOTHELIUM, VASCULAR; HEMANGIOENDOTHELIOMA, EPITHELIOID; HEMANGIOMA; HEMANGIOSARCOMA; HISTOCYTOLOGICAL PREPARATION TECHNIQUES; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM PROTEINS; NEOPLASMS, VASCULAR TISSUE; RABBITS; SARCOMA, KAPOSI; SENSITIVITY AND SPECIFICITY; TACROLIMUS BINDING PROTEIN 1A; TUMOR MARKERS, BIOLOGICAL; VASCULAR NEOPLASMS;

EID: 0037216515     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-200301000-00007     Document Type: Article

References (23)

1. Camp RL, Charette LA, Rimm DL. Validation of tissue microarray technology in breast carcinoma. Lab Invest 2000;80:1943-9.
2. Chaib H, Cockrell EK, Rubin MA, et al. Profiling and verification of gene expression patterns in normal and malignant human prostate tissues by cDNA microarray analysis. Neoplasia 2001;3: 43-52.
3. De Young BR, Frierson HF Jr, Ly MN, et al. CD31 immunoreactivity in carcinomas and mesotheliomas. Am J Clin Pathol 1998; 110:374-7.
4. Flanagan WM, Corthesy B, Brain RJ, et al. Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A. Nature 1991;352:803-7.
5. Folpe AL, Chand EM, Goldblum JR, et al. Expression of Fli-1, a nuclear transcription factor, distinguishes vascular neoplasms from potential mimics. Am J Surg Pathol 2001;25:1061-6.
6. Higgins JP, Warnke RA. CD30 expression is common in mediastinal large B-cell lymphoma. Am J Clin Pathol 1999;112:241-7.
7. Kallioniemi OP, Wagner U, Kononen J, et al. Tissue microarray technology for high-throughput molecular profiling of cancer. Hum Mol Genet 2001;10:657-62.
8. Kato H, Oikawa T, Otsuka K, et al. Postischemic changes in the immunophilin FKBP12 in the rat brain. Brain Res Mol Brain Res 2000;84:58-66.
9. Kononen J, Bubendoff L, Kallioniemi A, et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 1998;4:844-7.
10. Lesh RE, Marks AR, Somlyo AV, et al. Anti-ryanodine receptor antibody binding sites in vascular and endocardial endothelium. Circ Res 1993;72:481-8.
11. Liu J, Farmer JD Jr, Lane WS, et al. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 1991;66:807-15.
12. Miettinen M, Lindenmayer AE. Chaubal A. Endothelial cell markers CD31, CD34, and BNH9 antibody to H- and Y- antigens evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor. Mod Pathol 1994;7:82-90.
13. Monihan JM, Carr NJ, Sobin LH. CD34 immunoexpression in stromal tumors of the gastrointestinal tract and in mesenteric fibromatoses. Histopathology 1994;25:469-73.
14. Natkunam Y, Warnke RA, Montgomery K, et al. Analysis of MUMI/IRF4 protein expression using tissue microarrays and immunohistochemistry. Mod Pathol 2001;14:686-94.
15. Nishio H, Matsui K, Tsuji H, et al. Immunolocalization of calcineurin and FKBP12, the FK506-binding protein, in Hassall's corpuscles of human thymus and epidermis. Histochem Cell Biol 2000;114:9-14.
16. Rimm DL, Camp RL, Charette LA, et al. Tissue microarray: A new technology for amplification of tissue resources. Cancer J 2001; 7:24-31.
17. Rubin MA, Dunn R, Strawderman M, et al. Tissue microarray sampling strategy for prostate cancer biomarker analysis. Am J Surg Pathol 2002;26:312-9.
18. Ryan DH, Chapple CW, Kossover SA, et al. Phenotypic similarities and differences between CALLA-positive acute lymphoblastic leukemia cells and normal marrow CALLA-positive B cell precursors. Blood 1987;70:814-21.
19. Skacel M, Skilton B, Pettay JD, et al. Tissue microarrays: A powerful tool for high-throughput analysis of clinical specimens: A review of the method with validation data. Appl Immunohistochem Mol Morphol 2002;10:1-6.
20. Traweek ST, Kandalaft PL, Mehta P, et al. The human hematopoietic progenitor cell antigen (CD34) in vascular neoplasia. Am J Clin Pathol 1991;96:25-31.
21. Valdivia HH. Modulation of intracellular Ca2+ levels in the heart by sorcin and FKBP12, two accessory proteins of ryanodine receptors. Trends Pharmacol Sci 1998;19:479-82.
22. van de Rijn M, Hendrickson MR, Rouse RV. CD34 expression by gastrointestinal tract stromal tumors. Hum Pathol 1994;25:766-71.
23. Van de Rijn M, Lombard CM, Rouse RV. Expression of CD34 by solitary fibrous tumors of the pleura, mediastinum, and lung. Am J Surg Pathol 1994;18:814-20.